Showing results (21-30 of 4,006) with videos related to
Sort By:
Pageof 401
European Journal of Clinical Pharmacology|October 10, 1975
Comparative drug elimination in man-diphenylhydantoin and amobarbitalJ F Brien, T Inaba, W KalowDrug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1977
N-Hydroxylation of pentobarbital in manB K Tang, T Inaba, W KalowClinical Pharmacology and Therapeutics|May 1, 1978
Metabolism of cocaine in manT Inaba, D J Stewart, W KalowLife Sciences|January 2, 1984
Competitive inhibition of sparteine oxidation in human liver by beta-adrenoceptor antagonists and other cardiovascular drugsS V Otton, T Inaba, W KalowBritish Journal of Clinical Pharmacology|June 1, 1991
Oxidation of reduced haloperidol to haloperidol: involvement of human P450IID6 (sparteine/debrisoquine monooxygenase)R F Tyndale, W Kalow, T InabaDrug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1989
Evidence in humans for variant allozymes of the nondeficient sparteine/debrisoquine monooxygenase (P45OIID 1) in vitroR F Tyndale, T Inaba, W KalowResearch Communications in Chemical Pathology and Pharmacology|May 1, 1981
Antipyrine metabolites in two populationsT Inaba, H Uchino, D Kadar, et al.British Journal of Clinical Pharmacology|April 1, 1985
Genetic polymorphism of mephenytoin p(4')-hydroxylation: difference between Orientals and CaucasiansM Jurima, T Inaba, D Kadar, et al.Clinical Pharmacology and Therapeutics|November 1, 1984
Mephenytoin and sparteine pharmacogenetics in Canadian CaucasiansT Inaba, M Jurima, M Nakano, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1985
In vitro inhibition studies of two isozymes of human liver cytochrome P-450. Mephenytoin p-hydroxylase and sparteine monooxygenaseT Inaba, M Jurima, W A Mahon, et al.Pageof 401